Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study

Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study

Abstract Background The Accelerate PhenoTest® BC system (AXDX) is a novel assay for rapid bacterial identification and antimicrobial susceptibility (AST). We report an evaluation of its impact on treatment of patients with Gram-negative bacteremia (GNB) with a high risk of antimicrobial resistance (...

Full description

Bibliographic Details
Main Authors: Tal Brosh-Nissimov, Anka Tzur, Daniel Grupel, Amos Cahan, Nir Ma’aravi, Maya Heled-Akiva, Hasan Jawamis, Hanna Leskes, Erez Barenboim, Nadav Sorek
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Annals of Clinical Microbiology and Antimicrobials
Subjects:
Antimicrobial treatment
Antimicrobial susceptibility testing
Rapid identification
Rapid AST
Antibiotic stewardship
Gram negative bacteremia
Online Access:https://doi.org/10.1186/s12941-023-00619-6

Internet

https://doi.org/10.1186/s12941-023-00619-6

Similar Items